Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Cantú syndrome may be linked to pituitary adenomas.

Longer CAG repeats in gene linked to more severe hair loss in females.

Pili annulati is caused by a protein metabolism disorder affecting hair structure.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Early diagnosis and treatment of favus can prevent permanent hair loss.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The Itpr3 gene causes a specific hair pattern in mice.

One twin girl has Loose anagen syndrome with poorly anchored hair, diagnosed with a simple hair pull test, while her identical twin does not have the condition.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Four children had unmanageable pale blond hair due to uncombable-hair syndrome.